Clinical Trials Browser

Phase 2 × Contrast Media × Thoracic × Clear all

NCT03191149 2026-05-18

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07492121 2026-03-25

GAPIMET

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma